Abstract:IMPORTANCE Accumulating evidence supports the hypothesis that cerebral white matter abnormalities are involved in the pathophysiology of schizophrenia; however, findings from in vivo neuroimaging studies have been inconsistent. Besides confounding factors, including age, illness duration, and medication effects, an additional cause for the inconsistent results may be heterogeneity in the nature of white matter alterations associated with the disorder. OBJECTIVE To investigate whether different patterns of white matter abnormalities exist in a large cohort of medication-naive patients with first-episode schizophrenia and the relationship between such patterns and clinical parameters. DESIGN, SETTING, AND PARTICIPANTS A cross-sectional diffusion tensor imaging study of 113 medication-naive patients with first-episode schizophrenia and 110 demographically matched healthy control individuals. The study was conducted in the mental health center of West China Hospital, Sichuan University, Chengdu, China, from January 2006 to June 2014. MAIN OUTCOMES AND MEASURES The patterns of white matter abnormalities revealed by tract-specific analysis in conjunction with hierarchical clustering. RESULTS With diffusion features extracted from 18 fiber tracts, cluster analysis revealed 2 patterns of abnormalities. One pattern (42.5% of patient sample) showed widespread white matter abnormalities compared with matched healthy control individuals, while another pattern (57.5% of patient sample) only showed circumscribed regional white matter abnormalities, mainly in the left superior longitudinal fasciculus. Patients in these subgroups did not differ in demographic features; however, negative symptoms were more severe in patients with widespread white matter abnormalities. CONCLUSIONS AND RELEVANCE Two distinct patterns of white matter abnormalities exist at the early phase of schizophrenia, with those having global abnormalities experiencing more severe negative symptoms. The finding that distinct subgroups of patients with schizophrenia have different forms of white matter pathology may reflect qualitatively distinct genetic influences or neurodevelopmental alterations and thus represents a promising strategy for resolving neurobiological heterogeneity in the schizophrenia syndrome.

White Matter in Schizophrenia Treatment Resistance.

White Matter Microstructural Abnormalities in Patients with Late-Onset Schizophrenia Identified by a Voxel-Based Diffusion Tensor Imaging

Risperidone-induced Topological Alterations of Anatomical Brain Network in First-Episode Drug-Naive Schizophrenia Patients: a Longitudinal Diffusion Tensor Imaging Study

N-methyl-D-aspartate Receptor Antibody and White Matter Deficits in Schizophrenia Treatment-Resistance

Association of Cortical Thickness and Cognition with Schizophrenia Treatment Resistance.

Abnormal White Matter Microstructure in Drug-Naive First Episode Schizophrenia Patients Before and after Eight Weeks of Antipsychotic Treatment.

Two Patterns of White Matter Abnormalities in Medication-Naive Patients With First-Episode Schizophrenia Revealed by Diffusion Tensor Imaging and Cluster Analysis.

A Preliminary Study on Schizophrenia of Distinct Antipsychotic Response Based on Diffusion Tensor Imaging

White Matter Abnormalities in Never-Treated Patients with Long-Term Schizophrenia.

Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated with Clozapine or Risperidone and Those Never Treated

White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study

Structural white matter abnormalities in Schizophrenia and associations with neurocognitive performance and symptom severity

White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.

Elucidating the Relationship Between White Matter Structure, Demographic, and Clinical Variables in Schizophrenia—a Multicenter Harmonized Diffusion Tensor Imaging Study

Pretreatment Abnormalities in White Matter Integrity Predict One-Year Clinical Outcome in First Episode Schizophrenia

Reduced White Matter Integrity and Cognitive Deficit in Never-Medicated Chronic Schizophrenia: A Diffusion Tensor Study Using TBSS

The role of the white matter integrity of the anterior commissure in cognitive functions in first-episode schizophrenia

A White Matter Connection of Schizophrenia and Alzheimer's Disease.

Functional Alterations of White Matter in Chronic Never-Treated and Treated Schizophrenia Patients.

Reduced White Matter Integrity Associated with Cognitive Deficits in Patients with Drug-Naive First-Episode Schizophrenia Revealed by Diffusion Tensor Imaging.

Cognitive Deficits and Their White Matter Correlates in Schizophrenia